ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer

Hu, Xingbin; Ma, Zhenfeng; Xu, Beibei; Li, Shulong; Yao, Zhiqi; Liang, Bishan; Wang, Jiao; Liao, Wangjun; Lin, Li; Wang, Chunling; Zheng, Siting; Wu, Qijing; Huang, Qiong; Yu, Le; Wang, Fenghua*; Shi, Min*南方医科大学; 中山大学
Cancer Communications2023-8DOI: 10.1002/cac2.12459
2被引9阅读
引用收藏
分享

摘要

BackgroundTrastuzumab is a first-line targeted therapy for human epidermal growth factor receptor-2 (HER2)-positive gastric cancer. However, the inevitable occurrence of acquired trastuzumab resistance limits the drug benefit, and there is currently no effective reversal measure. Existing researches on the mechanism of trastuzumab resistance mainly focused on tumor cells themselves, while the understanding of the mechanisms of environment-mediated drug resistance is relatively lacking. This study aimed to further explore the mechanisms of trastuzumab resistance to identify strategies to promote survival in these patients. MethodsTrastuzumab-sensitive and trastuzumab-resistant HER2-positive tumor tissues and cells were collected for transcriptome sequencing. Bioinformatics were used to analyze cell subtypes, metabolic pathways, and molecular signaling pathways. Changes in microenvironmental indicators (such as macrophage, angiogenesis, and metabolism) were verified by immunofluorescence (IF) and immunohistochemical (IHC) analyses. Finally, a multi-scale agent-based model (ABM) was constructed. The effects of combination treatment were further validated in nude mice to verify these effects predicted by the ABM. ResultsBased on transcriptome sequencing, molecular biology, and in vivo experiments, we found that the level of glutamine metabolism in trastuzumab-resistant HER2-positive cells was increased, and glutaminase 1 (GLS1) was significantly overexpressed. Meanwhile, tumor-derived GLS1 microvesicles drove M2 macrophage polarization. Furthermore, angiogenesis promoted trastuzumab resistance. IHC showed high glutamine metabolism, M2 macrophage polarization, and angiogenesis in trastuzumab-resistant HER2-positive tumor tissues from patients and nude mice. Mechanistically, the cell division cycle 42 (CDC42) promoted GLS1 expression in tumor cells by activating nuclear factor kappa-B (NF-& kappa;B) p65 and drove GLS1 microvesicle secretion through IQ motif-containing GTPase-activating protein 1 (IQGAP1). Based on the ABM and in vivo experiments, we confirmed that the combination of anti-glutamine metabolism, anti-angiogenesis, and pro-M1 polarization therapy had the best effect in reversing trastuzumab resistance in HER2-positive gastric cancer. ConclusionsThis study revealed that tumor cells secrete GLS1 microvesicles via CDC42 to promote glutamine metabolism, M2 macrophage polarization, and pro-angiogenic function of macrophages, leading to acquired trastuzumab resistance in HER2-positive gastric cancer. A combination of anti-glutamine metabolism, anti-angiogenesis, and pro-M1 polarization therapy may provide a new insight into reversing trastuzumab resistance.

学科与关键词

关键词
Gastric cancerglutamine metabolismmacrophagemathematical modelmicrovesiclestrastuzumab
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancer Communications
发表日期
2023-08
卷期
第 43 卷, 第 8 期
页码
909-937
DOI
10.1002/cac2.12459
成果收录
SCIE

作者

  • H

    Hu, Xingbin (第一作者)

    southern med univ

  • M

    Ma, Zhenfeng

    southern med univ

查看全部 16 位作者收起作者
  • X

    Xu, Beibei

    southern med univ

  • L

    Li, Shulong

    southern med univ

  • Y

    Yao, Zhiqi

    southern med univ

  • L

    Liang, Bishan

    southern med univ

  • W

    Wang, Jiao

    southern med univ

  • L

    Liao, Wangjun

    southern med univ

  • L

    Lin, Li

    southern med univ

  • W

    Wang, Chunling

    southern med univ

  • Z

    Zheng, Siting

    southern med univ

  • W

    Wu, Qijing

    southern med univ

  • H

    Huang, Qiong

    southern med univ

  • Y

    Yu, Le

    southern med univ

  • W

    Wang, Fenghua (通讯)

    sun yat sen univ

  • S

    Shi, Min (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417